Statements 15 May 2026 DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
Stories Lab lessons that matter: Pharmacy students help bridge the gap in research for neglected diseases
Press releases 4 Mar 2026 Pandemic preparedness: Novo Nordisk Foundation renews its support to DNDi and THSTI to continue the development of broad-spectrum antivirals
